Routes to address the real challenges in serialisation

Published: 8-Mar-2017

A selection of webinars given by experts at Aesica Pharmaceuticals

With a counterfeit drug market now estimated at $200bn, many countries are putting serialisation legislation in place.

In this three part webinar series, Aesica’s experts will discuss the pharmaceutical industry’s preparedness for these regulatory requirements, practical methods to address the real challenges in serialisation now, and advice for planning for the future.

  1. Pharmaceutical Serialisation – The Challenges We, As a CDMO, Are Facing

    2. In this first webinar, Christian Groß, Manager Packaging Technology and Project Manager Serialisation, Aesica Pharmaceuticals will discuss the industry’s preparedness for serialisation legislation and Aesica’s serialisation solution, from concept to delivery.

  2. Serialisation Data Integration – Drug Safety, Security and The Whole IT Picture

    3. In this second webinar, Ralf Liedke, Director of IT Germany at Aesica, will discuss serial numbers and the corresponding details of Aesica’s serialisation solution.

  3. Pharmaceutical Serialisation – Opportunities and Aggregation in the Future

    4. In this third webinar, Catherine Kay, Operations Director at Aesica will discuss the challenges of serialisation and how serialisation capability could be developed to address future needs. For example, if patients can only afford a limited number of tablets at any given time, serialisation to the blister pocket level may be a future requirement.

  • Companies:
  • Aesica Pharmaceuticals
See more

You may also like

Manufacturing

Aesica to exhibit at CPhI Worldwide 2017

Read more
Aesica is a leading pharmaceutical contract development and manufacturing organisation for both API and finished dose forms

Trending Articles

  1. Counteracting counterfeits in the pharmaceutical supply chain Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
  2. Catalent Boston adds to oral spray drying capacity to support late-stage clinical trials and commercialisation Catalent, the leading provider of oral drug development solutions, bioavailability enhancing technologies and flexible manufacturing, has completed a series of upgrades to its large-scale spray drying unit (GEA PSD-4) at its Boston (MA, US) facility
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  4. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Industrial data mastery: navigating the 2025 landscape As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

Aesica to exhibit at CPhI Worldwide 2017

Aesica is a leading pharmaceutical contract development and manufacturing organisation for both API and finished dose forms
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

How contract manufacturers can bridge the innovation–commercialisation divide

With R&D budgets under pressure, the pharmaceutical industry would do well to look to the contract manufacturing sector for innovative approaches and technologies that could make production more effective and efficient, and achieve more with finite resources
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Serialisation regulations: the scale of the challenge

Meeting existing and future challenges in the market
Manufacturing

Aesica Pharmaceuticals implements Ci-DMS Weigh and Dispense from CI Precision

Analysis demonstrated that the MES Weigh and Dispense and SAP Interface modules would mitigate the risk of human error

Aesica offers serialisation solution which complies with regulations across multiple geographies

Flexible, fast, single platform for regulatory compliance across the globe
Manufacturing

Aesica adds development capability at Queenborough plant in Kent

Opens new purpose-built facility and expands services for highly potent and controlled drugs
Design & Build

Aesica relocates development and clinical manufacturing services from Nottingham to Queenborough, Kent

Offers double the capacity of the existing development centre
Subscribe now